Skip to main content

Non Invasive Prenatal Testing

Our non-invasive method test for foetal trisomy of chromosomes 21, 18 and 13, to identify foetal sex and to detect aneuploidies of sex chromosomes.

pregnant patient
These tests can be used by all pregnant women

Unilabs Genetics’ offers several non-invasive prenatal tests. These tests make use of a non-invasive technique that tests maternal blood for the presence of trisomy in chromosomes 21, 18 and 13 of the fetal DNA. The tests can also identify gender and detect numerical changes of sex chromosomes (monosomy X, XXX, XXY, XYY).

What do our NIPT tests detect?

Our tests detect:

  • Trisomy 21 (Down syndrome)
  • Trisomy 18 (Edwards syndrome)
  • Trisomy 13 (Patau syndrome)
  • Gender identification (fetal sex)
  • Numerical changes of sex chromosomes X and Y: Turner syndrome (MX), Triple X syndrome (XXX), Klinefelter syndrome (XXY), double Y syndrome (XYY)

Who should use these tests?

These tests can be used by all pregnant women, but they are particularly recommended for:

  • Pregnant women who wish to screen for the presence of these chromosomal aneuploidies in the foetus with a non-invasive procedure.
  • Pregnant women over the age of 35.
  • Pregnant women with increased risk of trisomies 21, 18 and 13.
  • Pregnant women with diagnosed trisomy in previous pregnancy.
  • Pregnant women with a history of recurrent miscarriage. 
  • Pregnant women who wish to know more about their baby.

These tests can also be performed in instances of:

  • Twin pregnancies (2 foetuses)*
  • Egg donation pregnancies (self-donation or not)

*Detection of trisomies 21, 18 and 13 and gender identification only. The NIPT tests cannot be performed in pregnancies with more than two foetuses.